Crinetics Pharmaceuticals Operating Expenses Growth & History (CRNX)

Crinetics Pharmaceuticals's operating expenses was $524.5M for fiscal 2025.

View full Crinetics Pharmaceuticals company overview

Crinetics Pharmaceuticals annual operating expenses history

Crinetics Pharmaceuticals annual operating expenses

Fiscal yearPeriod endedOperating expensesChangeGrowth
20252025-12-31$524.5M$184.6M+54.30%
20242024-12-31$339.9M$113.3M+49.98%
20232023-12-31$226.6M$54.0M+31.28%
20222022-12-31$172.6M$63.8M+58.69%
20212021-12-31$108.8M$33.8M+44.99%
20202020-12-31$75.0M$20.0M+36.35%
20192019-12-31$55.0M$23.9M+76.71%
20182018-12-31$31.1M$20.0M+178.71%
20172017-12-31$11.2M$4.5M+68.43%
20162016-12-31$6.6M

Crinetics Pharmaceuticals operating expenses trends

Over the last five fiscal years, Crinetics Pharmaceuticals's operating expenses increased from $75.0M to $524.5M, a change of $449.4M. The latest reported quarter, Q2 2026, shows $157.6M.

About the metric

What operating expenses mean

Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.

Calculation and source

SEC-reported and calculated operating expenses

TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Crinetics Pharmaceuticals source filings ↗

Community posts

It’s quiet here.

No posts about CRNX yet. Start the conversation.

Write the first post